OC
ATRS

Oppenheimer & Co’s Antares Pharma, Inc. ATRS Stock Holding History

Oppenheimer & Co’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-25,600
Closed -$86K – 1387
2018
Q3 		$86K Hold
25,600
– – ﹤0.01% 1313
2018
Q2 		$66K Hold
25,600
– – ﹤0.01% 1300
2018
Q1 		$56K Hold
25,600
– – ﹤0.01% 1308
2017
Q4 		$51K Sell
25,600
-26,000
-50% -$56.6K ﹤0.01% 1292
2017
Q3 		$167K Hold
51,600
– – ﹤0.01% 1207
2017
Q2 		$166K Sell
51,600
-5,300
-9% -$15K ﹤0.01% 1216
2017
Q1 		$162K Sell
56,900
-19,000
-25% -$45.7K ﹤0.01% 1210
2016
Q4 		$177K Sell
75,900
-26,000
-26% -$49.5K 0.01% 1177
2016
Q3 		$171K Sell
101,900
-10,400
-9% -$12.7K 0.01% 1168
2016
Q2 		$118K Buy
112,300
+18,000
+19% +$17.4K ﹤0.01% 1157
2016
Q1 		$82K Sell
94,300
-8,000
-8% -$7.74K ﹤0.01% 1192
2015
Q4 		$124K Buy
102,300
+26,200
+34% +$36.5K ﹤0.01% 1191
2015
Q3 		$129K Sell
76,100
-11,000
-13% -$21.6K ﹤0.01% 1239
2015
Q2 		$181K Buy
87,100
+11,000
+14% +$26.7K 0.01% 1325
2015
Q1 		$207K Sell
76,100
-3,400
-4% -$8.63K 0.01% 1287
2014
Q4 		$204K Sell
79,500
-38,073
-32% -$85.5K 0.01% 1214
2014
Q3 		$215K Buy
117,573
+38,673
+49% +$84.3K 0.01% 1216
2014
Q2 		$211K Buy
78,900
+12,172
+18% +$36.6K 0.01% 1235
2014
Q1 		$234K Sell
66,728
-66,141
-50% -$293K 0.01% 1162
2013
Q4 		$594K Buy
132,869
+60,465
+84% +$246K 0.02% 748
2013
Q3 		$294K Buy
72,404
+32,535
+82% +$142K 0.01% 978
2013
Q2 		$166K Buy
+39,869
New +$154K 0.01% 1142

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oppenheimer & Co's ATRS Position: Q4 2018 in Review

Oppenheimer & Co sold out of Antares Pharma, Inc. (ATRS) in Q4 2018, closing a stake of 25,600 shares — an estimated $86K sold.

Oppenheimer & Co first reported a position in ATRS in Q2 2013 and held it in 22 quarters. The position peaked at $594K in Q4 2013. 120 funds tracked by Wall St. Rank hold ATRS as of Q4 2018.

  • Oppenheimer & Co reported no remaining Antares Pharma, Inc. position as of Q4 2018 after selling out during the quarter.
  • Oppenheimer & Co sold 25,600 Antares Pharma, Inc. shares in Q4 2018, an estimated $86K.
  • Oppenheimer & Co first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 22 quarters.
  • Oppenheimer & Co's Antares Pharma, Inc. position peaked at $594K in Q4 2013.
  • 120 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2018.

Based on Oppenheimer & Co's 13F filing for Q4 2018, filed 29 Jan 2019.